Catalent is a U.S.-based global contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotech, and consumer health sectors. Headquartered in Somerset, New Jersey, it provides development, scale-up, and commercial manufacturing across a network of facilities in the Americas, Europe, and Asia.
The company’s capabilities span formulation and analytical services; oral dose and drug delivery technologies such as softgel capsules (including plant-based options), oral solid dose and modified-release forms, and orally disintegrating tablets; as well as sterile fill–finish and biologics manufacturing for proteins and advanced therapies. Catalent also offers clinical supply management, packaging, and serialization services supporting global launches.
Its operations cover prescription and over-the-counter medicines, nutritional supplements, and animal health products, with contained processing for highly potent and cytotoxic compounds. The company is also referred to as Catalent Pharma Solutions in connection with many of its service offerings.
To provide comprehensive coverage, we aggregate data and news under the name Catalent, encompassing the following company names, divisions, and related entities:
Catalent Pharma Solutions.
This list encompasses current and former names, alternate names, and key divisions associated with Catalent, ensuring you can easily find all relevant information under a single, unified profile.
